ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Tape-Assisted Residual Layer-Free One-Step Nanoimprinting of High-Index Hybrid Polymer for Optical Loss-Suppressed Metasurfaces.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Nanoimprinting of pressure-intolerant tilted nanostructures assisted by an electric field for high performance optical coupler.Microsystems & nanoengineering · 2026Article
- Extending the boundaries of ultraviolet-visible meta-optics via direct imprinting of tantalum pentoxide composite.Microsystems & nanoengineering · 2026Article
- Article
- Demolding Simulation of Propagation Phase Metasurfaces via Roll-to-Plate Nanoimprint.Micromachines · 2025Article
- Application of metasurface in future displays.Nanophotonics (Berlin, Germany) · 2025Review
- Review for optical metalens based on metasurfaces: fabrication and applications.Microsystems & nanoengineering · 2025Review
- Mechanically robust and self-cleanable encapsulated metalens via spin-on-glass packaging.Microsystems & nanoengineering · 2025Article
- Tape-Assisted Residual Layer-Free One-Step Nanoimprinting of High-Index Hybrid Polymer for Optical Loss-Suppressed Metasurfaces.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The commercialization of metasurfaces is crucial for real-world applications such as wearable sensors, pigment-free color pixels, and augmented and virtual reality devices. Nanoparticle-embedded resin-based nanoimprint lithography (PER-NIL) has shown itself to be a low-cost, high-throughput manufacturing method enabling the replication of high-index nanostructures. It has been extensively integrated into the fabrication of hologram metasurfaces, metalenses, and sensors due to its procedural simplicity. Most research on PER-NIL has been limited to exploring appropriate materials to enhance the efficiency of imprinted metasurfaces, but the intrinsic issue of PER-NIL lies in the high-index residual layer remaining on the substrate. This high-index residual layer generates undesired noise, limiting the efficiency and functionality of imprinted metasurfaces. Despite the need for the removal of the residual layer, it has never been experimentally achieved owing to the different etching rates between the nanoparticles and resin. Here, a new methodology named tape-assisted PER-NIL is proposed, achieving one-step removal of the residual layer using a tape. This novel method enables the replication of residual layer-free, high-index metasurfaces. As a result, imprinted residual layer-free metasurfaces prove their potential in high-purity dielectric structural colorations by achieving a sharp reflectance peak unattainable with conventional NIL, and in vivid hologram metasurfaces by covering a full 2π phase without unwanted scattering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.